Latest From Biotech Now

Post-election Scenarios to Microbiome Therapies—Diverse Panels at 2016 BIO Investor Forum

us_flag

Government policy and regulation, investment trends, latest discoveries, drug development, licensing and other topics will be covered during panel sessions at the 15th annual BIO Investor Forum Oct 18-19 in San Francisco. Among the varied educational topics covered during the conference is one that can only occur every four years: the presidential election. The presidential campaign is generating interest from all sectors of American society—and rightfully so. The decision made in November will impact all Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Should We Bring Extinct Species Back From the Dead?

Woolly_mammoth

For decades the notion of “de-extinction” hovered on the scientific fringes, Science‘s David Schultz stated in his recent article. Now new advances in genetic engineering, especially the CRISPR-Cas9 revolution, have researchers believing that it’s time to start thinking seriously about which animals we might be able to bring back, and which ones would do the most good for the ecosystems they left behind. In “Should we bring extinct species back from the dead?,” David Schultz explains what is de-extinction, Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Closing the Gender Gap in Biotech through SBIR/STTR Funding

sbir-sttr

Although progress has been made, there is no denying the biotech industry continues to have a large gender gap. Women hold only 16 percent of the senior management posts at the top pharma companies, and of senior executive positions at emerging companies — the 10 companies that raised most in venture capital A rounds in 2014 — only 12 (17 percent) were filled by women.* The National Center for Advancing Translational Sciences (NCATS), part of Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Why GMOs Are a Necessity

GMO-soybeans-665x385-150x150

After 20 years, the data are in:  Genetic modification boosts crop yields by 21 percent and cuts pesticides by 37 percent.  The Wall Street Journal ran an op-ed authored by Rob Fraley, executive vice president and chief technology officer of Monsanto, on how GMO’s benefit farmers and the environment: Genetically modified crops, which have generated both controversy and widespread adoption, are hitting 20-year milestones. Perhaps the anniversary slipped your mind, but 1997 was a dark Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Patent Reform Needs to Address Trolling of All Stripes

uspto-madison-main-copy

As we enter the final days of the 114th Congress, it is regrettable that the unintended consequences of the PTO’s administrative patent challenge system known as Inter Partes Review, or IPR, continue to threaten innovative, intellectual property-reliant companies that are helping to drive this nation’s economic growth. It is vital that patent reform legislative efforts crack down on abuses of the IPR system and impose greater checks on the unfettered discretion of the PTO’s administrative Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,